SNAP-8
An octapeptide cosmetic ingredient extending the Argireline concept — same SNAP-25 competitive mechanism with two additional residues and claims of enhanced activity.
An elongated version of Argireline (acetyl octapeptide-3) marketed by Lipotec as a second-generation SNAP-25 mimic for topical expression-line reduction.
Mechanism of action
Same mechanism as Argireline — competes with SNAP-25 at the SNARE complex, reducing acetylcholine release at the neuromuscular junction. Manufacturer studies claim enhanced potency vs Argireline at equivalent concentrations, but independent replication is limited.
Primary uses
- Topical anti-aging cosmetic formulations
Typical dosing
Cosmetic concentrations.
Regulatory status
Cosmetic ingredient; not a drug.
References
- [manufacturer] Lipotec. "SNAP-8 technical data sheet and cosmetic ingredient profile."
Related peptides
Guides & tools
Explore with tools
This entry is for educational purposes only and does not constitute medical advice. Dosing information reflects published regulatory or research data and is not a recommendation. Many compounds described here are not approved for human use in the United States. Consult a licensed medical professional before considering any peptide therapy.